Cellebrite DI Ltd. – NASDAQ:CLBTW

Financial Health
0
1
2
3
4
5
6
7
8
9

Cellebrite DI Ltd. stock price monthly change

-9.54%
month

Cellebrite DI Ltd. stock price quarterly change

+28.50%
quarter

Cellebrite DI Ltd. stock price yearly change

+175.00%
year

Cellebrite DI Ltd. key metrics

Market Cap
1.05B
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-0.57
Revenue
343.45M
EBITDA
52.60M
Income
-111.86M
Revenue Q/Q
25.75%
Revenue Y/Y
22.88%
Profit margin
44.64%
Oper. margin
0.39%
Gross margin
81.25%
EBIT margin
0.39%
EBITDA margin
15.32%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cellebrite DI Ltd. stock price history

Cellebrite DI Ltd. stock forecast

Cellebrite DI Ltd. financial statements

Cellebrite DI Ltd. (NASDAQ:CLBTW): Profit margin
Jun 2023 76.68M -32.34M -42.18%
Sep 2023 84.17M 6.5M 7.72%
Dec 2023 93.01M -14.64M -15.75%
Mar 2024 89.58M -71.37M -79.67%
0%
Yield TTM
Cellebrite DI Ltd. (NASDAQ:CLBTW): Payout ratio
Payout ratio 0%
Cellebrite DI Ltd. (NASDAQ:CLBTW): Dividend Yield
2019 1.38%
2020 0.77%
2021 8.66%
2022
2023
Cellebrite DI Ltd. (NASDAQ:CLBTW): Debt to assets
Jun 2023 425893000 408.33M 95.88%
Sep 2023 476942000 439M 92.04%
Dec 2023 540397000 506.18M 93.67%
Mar 2024 529136999 555.84M 105.05%
Cellebrite DI Ltd. (NASDAQ:CLBTW): Cash Flow
Jun 2023 16.57M -10.74M 5.68M
Sep 2023 29.17M -10.89M 8.81M
Dec 2023 43.82M 3.16M 4.53M
Mar 2024 10.04M -81.59M 5.06M

Cellebrite DI Ltd. alternative data

Cellebrite DI Ltd. (NASDAQ:CLBTW): Employee count
Jan 2024 1,005
Feb 2024 1,005
Mar 2024 1,008
Apr 2024 1,008
May 2024 1,008
Jun 2024 1,008
Jul 2024 1,008

Cellebrite DI Ltd. other data

1.15% -5.49%
of CLBTW is owned by hedge funds
2.24M -10.64M
shares is hold by hedge funds
  • When is Cellebrite DI Ltd.'s next earnings date?

    Unfortunately, Cellebrite DI Ltd.'s (CLBTW) next earnings date is currently unknown.

  • Does Cellebrite DI Ltd. pay dividends?

    No, Cellebrite DI Ltd. does not pay dividends.

  • How much money does Cellebrite DI Ltd. make?

    Cellebrite DI Ltd. has a market capitalization of 1.05B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20.12% to 325.11M US dollars.

  • What is Cellebrite DI Ltd.'s stock symbol?

    Cellebrite DI Ltd. is traded on the NASDAQ under the ticker symbol "CLBTW".

  • What is Cellebrite DI Ltd.'s primary industry?

    Company operates in the Technology sector and Software - Infrastructure industry.

  • How do i buy shares of Cellebrite DI Ltd.?

    Shares of Cellebrite DI Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Cellebrite DI Ltd. have?

    As Jul 2024, Cellebrite DI Ltd. employs 1,008 workers.

Cellebrite DI Ltd. company profile:

Cellebrite DI Ltd.

Exchange:

NASDAQ

Full time employees:

1,008

Industry:

Software - Infrastructure

Sector:

Technology

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.


,

CIK: 0001854587
ISIN: IL0011794984
: